September 22, 2022
The Ministry of Health, Labor and Welfare (MHLW) on September 21 granted orphan drug designation to two APIs including Daiichi Sankyo’s antibody drug conjugate (ADC) Enhertu (trastuzumab deruxtecan). Enhertu gained the status for an additional indication of HER2 mutant unresectable...read more